Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Osteoblastoma D018215 1 associated lipids
Erythromelalgia D004916 1 associated lipids
Fibromuscular Dysplasia D005352 2 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Drowning D004332 2 associated lipids
Jejunal Diseases D007579 3 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Radiculopathy D011843 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Billings PC et al. Effect of modifiers of arachidonic acid metabolism on radiation transformation and eicosanoid formation in C3H/10T1/2 cells. 1994 Cancer Biochem. Biophys. pmid:7728742
Karmali RA et al. Eicosanoids and metastasis: experimental aspects in Lewis lung carcinoma. 1986 Cancer Biochem. Biophys. pmid:3815323
Chen GG et al. Increased thromboxane B(2) levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma. 2006 Cancer Lett. pmid:15876485
Jacoby RF et al. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. 1996 Cancer Res. pmid:8631000
Klausner JM et al. Role of thromboxane in interleukin 2-induced lung injury in sheep. 1989 Cancer Res. pmid:2786452
Chiabrando C et al. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor. 1987 Cancer Res. pmid:3100032
Yang VW et al. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. 1998 Cancer Res. pmid:9563494
Leahy KM et al. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. 2002 Cancer Res. pmid:11830509
Furuta Y et al. Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin. 1988 Cancer Res. pmid:3130182
Hubbard WC et al. Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumors. 1989 Cancer Res. pmid:2536293
Jacoby RF et al. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. 2000 Cancer Res. pmid:11016626
Aitokallio-Tallberg AM et al. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma. 1991 Cancer Res. pmid:1868436
Ogura Y et al. Chemoprevention of biliary carcinogenesis in syrian hamsters by the novel carboxamide derivative IS-741 after initiation with N-nitrosobis(2-oxopropyl)amine (BOP). 2000 Carcinogenesis pmid:10910946
Sundström H et al. Serum selenium and thromboxane in patients with gynaecological cancer. 1986 Carcinogenesis pmid:3719901
Sundström H et al. Supplementation with selenium, vitamin E and their combination in gynaecological cancer during cytotoxic chemotherapy. 1989 Carcinogenesis pmid:2912578
Postula M et al. Association of plasma concentrations of salicylic acid and high on ASA platelet reactivity in type 2 diabetes patients. 2013 Cardiol J pmid:23558875
Davì G et al. [Effects of flurbiprofen on the platelet function in patients with ischemic cardiopathy]. 1982 Cardiologia pmid:6892383
De Caterina R et al. [Effects of isosorbide dinitrate on platelet aggregation and production of thromboxane B2]. 1982 Cardiologia pmid:6892461
De Caterina R et al. [Effect of isosorbide dinitrate on platelet aggregation and production of thromboxane B2]. 1982 Cardiologia pmid:6927441
Davì G et al. [Effects of flurbiprofen on platelet function in patients with ischemic cardiomyopathy]. 1982 Cardiologia pmid:6927457
Svenstrup Poulsen T et al. A critical appraisal of the phenomenon of aspirin resistance. 2005 Cardiology pmid:16020925
Lefkos N et al. Hemodynamic and biochemical changes after chronic administration of cilazapril to hypertensive patients. 1993 Cardiology pmid:8402751
Fiedler VB and Abram TS Effects of intracoronary leukotriene D4 infusion on the coronary circulation, hemodynamics, and prostanoid release in porcine experiments. 1987 Cardiology pmid:3568058
Kaplon-Cieslicka A et al. Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study. 2014 Cardiovasc Diabetol pmid:25123549
Liu H et al. Aspirin inhibits fractalkine expression in atherosclerotic plaques and reduces atherosclerosis in ApoE gene knockout mice. 2010 Cardiovasc Drugs Ther pmid:19997773
Gennaro M et al. Perfluorocarbon emulsion prevents eicoasanoid release in skeletal muscle ischemia and reperfusion. 1996 Cardiovasc Surg pmid:8782946
Tanabe M et al. Coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion in anaesthetised dogs. 1982 Cardiovasc. Res. pmid:7074670
Eligini S et al. Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: role of transforming growth factor-beta1. 2007 Cardiovasc. Res. pmid:17250815
Takahashi K et al. The hypertensive response to vasopressor agents stimulates the release of thromboxane A2 in hypercholesterolaemic rabbits. 1989 Cardiovasc. Res. pmid:2514996
Hsiao G et al. Characterization of a novel and potent collagen antagonist, caffeic acid phenethyl ester, in human platelets: in vitro and in vivo studies. 2007 Cardiovasc. Res. pmid:17560560
Eligini S et al. Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism. 2006 Cardiovasc. Res. pmid:16154551
Terres W et al. Effects of streptokinase, urokinase, and recombinant tissue plasminogen activator on platelet aggregability and stability of platelet aggregates. 1990 Cardiovasc. Res. pmid:2167173
Bailey IA et al. Effects of vascular trauma and transient myocardial ischaemia on coronary venous prostaglandin levels in the dog. 1983 Cardiovasc. Res. pmid:6688202
Mink SN et al. Effect of bolus epinephrine on systemic hemodynamics in canine anaphylactic shock. 1998 Cardiovasc. Res. pmid:10070496
Foudi N et al. Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation. 2009 Cardiovasc. Res. pmid:18952694
Stanke-Labesque F et al. Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition. 2000 Cardiovasc. Res. pmid:10946074
Duda MK et al. Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. 2009 Cardiovasc. Res. pmid:19015135
Yano T et al. Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury. 2011 Cardiovasc. Res. pmid:21169294
Bode-Böger SM et al. Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo. 1998 Cardiovasc. Res. pmid:9659460
Nidorf SM et al. Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina. 1989 Cardiovasc. Res. pmid:2590911
Mak IT et al. Cardiac pathologic effects of azidothymidine (AZT) in Mg-deficient mice. 2004 Cardiovasc. Toxicol. pmid:15371632
Bultasová H et al. [Decreased activity of the renal vasodilation and natriuretic system in normotensive men with a familial history of essential hypertension and decreased Na+, K+-cotransport in erythrocytes]. 1986 Cas. Lek. Cesk. pmid:3536113
Honzlová M and Starý S [Eicosanoids and rheumatic disease]. 1986 Cas. Lek. Cesk. pmid:3779779
Petrů I et al. [Prostaglandins and chronic proliferative glomerulonephritis]. 1989 Cas. Lek. Cesk. pmid:2655914
Di Donato M et al. Blood velocity in the coronary artery circulation: relation to thromboxane A2 levels in coronary sinus in patients with angiographically normal coronary arteries. 1987 May-Jun Cathet Cardiovasc Diagn pmid:3594557
Zotz RJ et al. High-speed rotational angioplasty-induced echo contrast in vivo and in vitro optical analysis. 1992 Cathet Cardiovasc Diagn pmid:1606610
Stine RA et al. Failure of percutaneous transluminal coronary angioplasty to stimulate platelet and prostaglandin activity. 1985 Cathet Cardiovasc Diagn pmid:3160477
Kawaguchi T et al. The human megakaryocytic cell line UT-7/TPO expresses functional platelet agonist signals mediated through GPVI and thromboxane receptor. 2010 Cell Biol. Int. pmid:20522022
Francois H et al. Prostacyclin protects against elevated blood pressure and cardiac fibrosis. 2005 Cell Metab. pmid:16154102
Kanzaki Y et al. Thromboxane as possible trigger of liver regeneration. 1979 Cell Mol Biol Incl Cyto Enzymol pmid:535003
Miura Y and Fukui N Prostaglandins as possible triggers for liver regeneration after partial hepatectomy. A review. 1979 Cell Mol Biol Incl Cyto Enzymol pmid:44483
Clayton HA et al. A coculture model of intrahepatic islet transplantation: activation of Kupffer cells by islets and acinar tissue. 2001 Jan-Feb Cell Transplant pmid:11294466
Schenkein HA LPS-stimulated release of prostaglandin E and thromboxane B2 from the U937 cell line. 1986 Cell. Immunol. pmid:3100058
Storch J and MacDermot J IgE and IgG are synergistic in antigen-mediated release of thromboxane from human lung macrophages. 1991 Cell. Immunol. pmid:1826465
Bromberg Y and Pick E Unsaturated fatty acids as second messengers of superoxide generation by macrophages. 1983 Cell. Immunol. pmid:6307532
Harizi H et al. Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells. 2004 Cell. Immunol. pmid:15219461
Rocklin RE et al. Augmentation of prostaglandin and thromboxane production in vitro by monocytes exposed to histamine-induced suppressor factor (HSF). 1983 Cell. Immunol. pmid:6573232
Borst O et al. Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation. 2013 Cell. Physiol. Biochem. pmid:23817201
Towhid ST et al. Stimulation of platelet death by vancomycin. 2013 Cell. Physiol. Biochem. pmid:23363637
Winther K and Hedman C Beta-adrenoceptor blockade, platelets, and rheologic factors. 1986 Cephalalgia pmid:2879630
Galli C et al. Modification of brain vascular eicosanoids after pharmacological treatment and ischemia in the rat: drugs and brain vascular eicosanoids. 1985 Cephalalgia pmid:3839438
Hohlfeld T et al. Variable platelet response to aspirin in patients with ischemic stroke. 2007 Cerebrovasc. Dis. pmid:17519543
Helgason CM et al. Platelet aggregation and recruitment with aspirin-clopidogrel therapy. 2008 Cerebrovasc. Dis. pmid:18349532
Dippel DW et al. What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke? 2004 Cerebrovasc. Dis. pmid:15026612
Nosál R et al. [The effect of antihistamines on stimulated blood platelet functions]. 1995 Cesk Fysiol pmid:7758143
Hong S et al. Maresin-like lipid mediators are produced by leukocytes and platelets and rescue reparative function of diabetes-impaired macrophages. 2014 Chem. Biol. pmid:25200603
Kapetanovic IM et al. Comparison of pharmacokinetic and pharmacodynamic profiles of aspirin following oral gavage and diet dosing in rats. 2009 Chem. Biol. Interact. pmid:18992230
Selley ML et al. Effects of acrolein on human platelet aggregation. 1990 Chem. Biol. Interact. pmid:2118426
Wu G et al. Pravastatin inhibits plaque rupture and subsequent thrombus formation in atherosclerotic rabbits with hyperlipidemia. 2013 Chem. Pharm. Bull. pmid:23207681
Ishibashi M et al. The diethylhydrogensilyl-cyclic diethylsilylene derivative in the gas chromatography-mass spectrometry of thromboxane B2. 1986 Chem. Pharm. Bull. pmid:3791525
Ishibashi M et al. Feasibility of using [18O2]11-dehydrothromboxane B2 as an internal standard of immunoaffinity purification followed by gas chromatography/selected ion monitoring. 1989 Chem. Pharm. Bull. pmid:2632066
Sakurai S et al. Synthesis of [[(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives containing pyridyl or imidazolyl groups and their thromboxane A2 receptor antagonistic and thromboxane A2 synthase inhibitory activities. 1996 Chem. Pharm. Bull. pmid:8795270
Wassef NM and Alving CR Complement-dependent phagocytosis of liposomes. 1993 Chem. Phys. Lipids pmid:8242836
Ferretti A and Flanagan VP Mass spectrometric evidence for the anomalous chemical behavior of 11-dehydrothromboxane B2. 1995 Chem. Phys. Lipids pmid:7586090
Boatman RJ et al. Covalent protein adducts of hydroquinone in tissues from rats: quantitation of sulfhydryl-bound forms following single gavage or intraperitoneal administration or repetitive gavage administration. 2000 Chem. Res. Toxicol. pmid:10995259
Vani G et al. Histone H1 modulates immune status in experimental breast cancer. 2003 Chemotherapy pmid:14504437
Tanaka S et al. High dose of inhaled fluticasone reduces high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma. 2003 Chest pmid:14605047
Suzuki S et al. Evidence of acute inflammatory response in reexpansion pulmonary edema. 1992 Chest pmid:1729087
Obase Y et al. Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma. 1998 Chest pmid:9792572
Rich S et al. Thromboxane synthetase inhibition in primary pulmonary hypertension. 1987 Chest pmid:3545698
Spector SL et al. Clinical response and serum prostaglandin levels in aspirin idiosyncrasy. Effect of aspirin and a new nonsteroidal anti-inflammatory agent. 1981 Chest pmid:7307588
Zwischenberger JB et al. Pathophysiology of ovine smoke inhalation injury treated with extracorporeal membrane oxygenation. 1993 Chest pmid:8486048
Klotz TA et al. Urinary excretion of thromboxane B2 in patients with venous thromboembolic disease. 1984 Chest pmid:6697787
Kurokawa K et al. Circadian characteristics of urinary leukotriene E(4) in healthy subjects and nocturnal asthmatic patients. 2001 Chest pmid:11742908
Obase Y et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. 2002 Chest pmid:11796443
Kraft M et al. The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma. 1997 Chest pmid:9149578
Mathru M et al. Effect of fast vs slow intralipid infusion on gas exchange, pulmonary hemodynamics, and prostaglandin metabolism. 1991 Chest pmid:1989806
Hardie WD et al. Effects of intravenous amphotericin B infusion on hemodynamics and airway mechanics in awake sheep. 1991 Chest pmid:1989809
Barst RJ and Stalcup SA Endothelial function in clinical pulmonary hypertension. 1985 Chest pmid:3899537
Sylvester JT et al. Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction. 1985 Chest pmid:3840073
Yugar-Toledo JC et al. Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. 2004 Chest pmid:15006938
Wu JX et al. Changes in somatostatin receptor expression of the pancreas and effectiveness of octreotide in rats with acute necrotizing pancreatitis. 2004 Chin J Dig Dis pmid:15612670
Xue J et al. Inhibitory effects of Qushuanling Capsule () on thrombus formation and platelet aggregation in rats. 2013 Chin J Integr Med pmid:23001461
Chen HI et al. Effects of acute exercise on the biosynthesis of eicosanoids in rats. 1992 Chin J Physiol pmid:1295717
Teng CM et al. Antiplatelet action of dehydrokawain derivatives isolated from Alpinia speciosa rhizoma. 1990 Chin J Physiol pmid:2376215
Duan M et al. Factors involved in the neuronal death during postischemic reperfusion: experimental study in rabbits. 1999 Chin. Med. J. pmid:11593584
Fan YM et al. The effect of edible black tree fungus (Auricuaria auricula) on experimental atherosclerosis in rabbits. 1989 Chin. Med. J. pmid:2505974
Di GX et al. Exercise therapy of non-insulin dependent diabetes mellitus. Effects of acute exercise loading. 1993 Chin. Med. J. pmid:8222889
Li G et al. Ischemic preconditioning enhances donor lung preservation in canine lung transplantation. 1998 Chin. Med. J. pmid:11189228
Yang CS and Zhang LZ Prostacyclin and thromboxane in pregnancy-induced hypertension. 1988 Chin. Med. J. pmid:3150739